Back to OPNT Stock Lookup

Opnet Technologies, Inc. (OPNT) – Company Press Releases

Nov 10, 2016 07:00 AM Opiant Pharmaceuticals, Inc. Announces Appointment of Thomas T. Thomas to Board of Directors
Oct 31, 2016 07:00 AM Opiant Pharmaceuticals, Inc. Reports Fiscal Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update
Oct 28, 2016 07:00 AM Opiant Pharmaceuticals, Inc. Licenses Heroin Vaccine From Walter Reed Army Institute of Research and National Institute on Drug Abuse
Oct 27, 2016 07:00 AM Opiant Pharmaceuticals, Inc. Announces FDA Orange Book Listing for Narcan® Nasal Spray Patent
Oct 5, 2016 08:05 AM Opiant Pharmaceuticals, Inc.’s Partner, Adapt Pharma Limited, Announces NARCAN® Nasal Spray Approved by Health Canada
Aug 18, 2016 08:45 AM Opiant Pharmaceuticals to Present at the Rodman & Renshaw Conference on September 13 in New York City
Jun 9, 2016 08:00 AM Opiant Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2016 Financial Results and Provides Corporate Update
May 12, 2016 08:00 AM Opiant Pharmaceuticals, Inc. Announces Appointments of Gabrielle A. Silver, M.D., and Ann MacDougall to Board of Directors
May 6, 2016 08:30 AM Opiant Pharmaceuticals, Inc.’s Partner, Adapt Pharma Limited, Submits New Drug Submission for Naloxone Nasal Spray to Health Canada
Mar 16, 2016 08:30 AM Opiant Pharmaceuticals, Inc., Reports Fiscal Second Quarter 2016 Financial Results and Provides Corporate Update
Mar 7, 2016 04:05 PM Opiant Pharmaceuticals, Inc., Announces Ticker Symbol Change to “OPNT”
Jul 20, 2015 04:00 AM Tenable Network Security Appoints Ron Kaiser to Board of Directors as Audit Committee Chair

Back to OPNT Stock Lookup